Journal Mobile Options
Table of Contents
Vol. 83, No. 3-4, 1998
Issue release date: 1998
Cytogenet Cell Genet 83:256–257 (1998)

Assignment1 of the oxoglutarate carrier gene (SLC20A4) to human chromosome 17p13.3

Piccininni S.a · Iacobazzi V.b · Lauria G.b · Rocchi M.a · Palmieri F.b
aIstituto di Genetica, bDipartimento Farmaco-Biologico, Università di Bari, Bari (Italy)

First-Page Preview
Abstract of Paper

 goto top of outline Author Contacts

Request reprints from Dr. M. Rocchi, Istituto di Genetica, via Amendola 165/A,70126 Bari (Italy); telephone: +39-080-544.3371; fax: +39-080544.3386;e-mail:

 goto top of outline Article Information

Supported in part by AIRC, CNR, CNR Target Project on Biotechnology, and MURST. The financial support of Telethon-Italy (Grants E.672 and 985) is gratefully acknowledged.

Received: Received 7 April 1998;
revision accepted 4 November 1998.
Number of Print Pages : 2

 goto top of outline Publication Details

Cytogenetics and Cell Genetics
Founded 1962 as Cytogenetics by H.P. Klinger

Vol. 83, No. 3-4, Year 1998 (Cover Date: 1998)

Journal Editor: H.P. Klinger, New York, USA
ISSN: 0301–0171 (print), 1422–9816 (Online)

For additional information:

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.